Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322360/
https://www.ncbi.nlm.nih.gov/pubmed/37416219
http://dx.doi.org/10.1155/2023/9823491
_version_ 1785068736780173312
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10322360
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103223602023-07-06 Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-06-28 /pmc/articles/PMC10322360/ /pubmed/37416219 http://dx.doi.org/10.1155/2023/9823491 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
title Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
title_full Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
title_fullStr Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
title_full_unstemmed Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
title_short Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
title_sort retracted: effect of parp inhibitor combined with bevacizumab on platinum-resistant recurrent ovarian epithelial carcinoma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322360/
https://www.ncbi.nlm.nih.gov/pubmed/37416219
http://dx.doi.org/10.1155/2023/9823491
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedeffectofparpinhibitorcombinedwithbevacizumabonplatinumresistantrecurrentovarianepithelialcarcinoma

Ejemplares similares